NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
06/29/2020
Back to search
Official data from USPTO
E L I EFFICIENT LABORATORIES, INC.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
06/29/2020
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
08/12/1999
Registration date
06/12/2001
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/29/2020
Last transaction
06/29/2020
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
06/01/1999
First use in commerce
06/01/1999
Drawing code
5
Owner type
16
Owner location
MIAMI, FL, US
Examiner
BELL, MARLENE D
Law office
L50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
CULEBRA HOLDINGS, LLC
Efficient Laboratories, Inc.
Efficient Laboratories, Inc.
Representatives
Delaila J. Estefano ESTEFANO LAW, P.A.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical productsnarcotic antitussivesnon- narcotic antitussivescough expectorantsvitamin supplements containing minerals nutritional supplementsmuscle relaxants and pain relieversskin lotions for the treatment of fungustreatment for athletes' foot and ringwormherbal preparation used to relieve stressmedicines to treat cold sores
Publications
History of USPTO decisions and trademark events.
31 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
06/29/2020
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/29/2020
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
06/24/2020
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
06/22/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/22/2020
E89R
TEAS SECTION 8 & 9 RECEIVED
06/16/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/12/2020
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/22/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/23/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/02/2012
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/02/2012
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
06/29/2010
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/29/2010
E89R
TEAS SECTION 8 & 9 RECEIVED
06/28/2010
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/13/2009
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/13/2009
CFIT
CASE FILE IN TICRS
10/17/2006
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/14/2006
PLGL
ASSIGNED TO PARALEGAL
09/07/2006
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
06/20/2006
E815
TEAS SECTION 8 & 15 RECEIVED
06/20/2006
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/19/2006
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/19/2006
R.PR
REGISTERED-PRINCIPAL REGISTER
06/12/2001
PUBO
PUBLISHED FOR OPPOSITION
03/20/2001
NPUB
NOTICE OF PUBLICATION
03/07/2001
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/21/2000
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/16/2000
CNRT
NON-FINAL ACTION MAILED
11/24/1999
DOCK
ASSIGNED TO EXAMINER
11/19/1999
Continuous trademark protection
Get notified about every new filing that threatens E L I EFFICIENT LABORATORIES, INC. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.